FDA Approves Pancreatic Enzyme Products to Aid Digestion

02 Mar 2012 --- Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Mar 2 2012 --- Two new pancreatic enzyme products used to help aid food digestion, Ultresa (pancrelipase) and Viokace (pancrelipase), were approved by the U.S. Food and Drug Administration.

Ultresa is a delayed-release capsule used to treat children and adults with cystic fibrosis, a serious genetic disorder affecting the lungs and other organs, or other conditions who cannot digest food normally because their pancreas does not make enough pancreatic enzymes.

Viokace, in combination with a proton pump inhibitor, is used to treat adults who cannot digest food normally. Adults with chronic pancreatitis, a continuing, chronic inflammatory process of the pancreas, or those who have had some or all of their pancreases removed (pancreatectomy) may not digest food normally because they lack needed enzymes or because their enzymes are not released into the bowel (intestine). Viokace’s safety and efficacy in children has not been established.

“The approvals of Ultresa and Viokace, along with the other approved pancreatic enzyme products, allow health care providers to prescribe the product that is most appropriate for the estimated 200,000 patients in the United States who have pancreatic insufficiency,” said Julie Beitz, M.D., director of the Office of Drug Evaluation III in FDA’s Center for Drug Evaluation and Research.

Ultresa and Viokace are the fourth and fifth pancreatic enzyme products approved by FDA. Other FDA-approved pancreatic enzyme products include Creon (2009), Zenpep (2009) and Pancreaze (2010). Approved pancreatic enzyme products meet FDA standards for safety, efficacy and product quality.

Unapproved pancreatic enzyme products had been available for many years. FDA established a date of April 28, 2010 for the makers of pancreatic enzyme products to stop manufacturing and distributing unapproved products.

Ultresa and Viokace are marketed by Bridgewater, N.J.-based Aptalis Pharma U.S. Inc.
 

Related Articles

Health & Nutrition News

Applied Food Sciences Secure Patent for Producing Guayusa Extract

28 Mar 2017 --- Applied Food Sciences, Inc. (AFS) has announced it is now the exclusive owner of a process patent that covers the production of enriched natural guayusa, from a single source plant, containing antioxidants, amino acids and caffeine.

Business News

KEY INTERVIEW: Innovating with Plants & Bridging the Gap Between Plant and Synthetic Molecules

28 Mar 2017 --- The trend towards more natural, cleaner label products is nothing new, yet the innovation side of the trend continues to surprise and delight the industry. Kemin are certainly leaders in innovation, and today Stefaan Van Dyck, the President of the food technologies division talks to NutritionInsight about bridging the gap between synthetic and natural preservatives and how plant technology can both promote  freshness of food and protect the nutritional value of food products in a way that will appeal to the modern customer.

Health & Nutrition News

Medicinal Food Diet Effective Against Type 1 Diabetes, Finds Study

28 Mar 2017 --- By following a diet high in short-chain fatty acids, humans may be able to improve their immune system and protect against type 1 or juvenile diabetes. That’s according to Monash University’s Biomedicine Discovery Institute where researchers say their new findings illustrate the dawn of a new era in treating human disease with medicinal foods.

Health & Nutrition News

Discounting and Promotions Contribute to Childhood Obesity, Claims UK Health Committee

27 Mar 2017 --- Members of the UK Government have declared that more robust action is needed in order to tackle the impact of deep discounting and price promotions on the sales of unhealthy food and drink. The statement comes as part of the Health Committee’s follow up report into childhood obesity. 

More Articles
URL : http://www.nutritioninsight.com:80/news/FDA-Approves-Pancreatic-Enzyme-Products-to-Aid-Digestion.html